Application
Western blot analysis of PRAS40 (pT246) expression in LO2 (A); Raw264.7 (B); NIH3T3 (C) whole cell lysates.
WB
e Effects of LY294002 (a PI3K inhibitor) or AKT siRNA on the levels of total AKT, pAKT, phosphorylated PRAS40 (Proline-rich AKT substrate 40 kDa) and pMDM2 were examined by Western blot analysis in MCF-7 cells when HBXIP was overexpressed. f Effects of MK-2206 (an AKT inhibitor) or HBXIP siRNA on the levels of total AKT, pAKT, pPRAS40, and pMDM2 were examined by Western blot analysis in MCF-7-HBXIP cells.